Abstract
PurposeTo determine the diagnostic performance of FDG-PET/MRI with diffusion-weighted imaging (FDG-PET/DWIMRI) for detection and local staging of head and neck squamous cell carcinoma (HNSCC) after radio(chemo)therapy.Materials and methodsThis was a prospective study that included 74 consecutive patients with previous radio(chemo)therapy for HNSCC and in whom tumour recurrence or radiation-induced complications were suspected clinically. The patients underwent hybrid PET/MRI examinations with morphological MRI, DWI and FDG-PET. Experienced readers blinded to clinical/histopathological data evaluated images according to established diagnostic criteria taking into account the complementarity of multiparametric information. The standard of reference was histopathology with whole-organ sections and follow-up ≥24 months. Statistical analysis considered data clustering.ResultsThe proof of diagnosis was histology in 46/74 (62.2%) patients and follow-up (mean ± SD = 34 ± 8 months) in 28/74 (37.8%). Thirty-eight patients had 43 HNSCCs and 46 patients (10 with and 36 without tumours) had 62 benign lesions/complications. Sensitivity, specificity, and positive and negative predictive value of PET/DWIMRI were 97.4%, 91.7%, 92.5% and 97.1% per patient, and 93.0%, 93.5%, 90.9%, and 95.1% per lesion, respectively. Agreement between imaging-based and pathological T-stage was excellent (kappa = 0.84, p < 0.001).ConclusionFDG-PET/DWIMRI yields excellent results for detection and T-classification of HNSCC after radio(chemo)therapy.Key points• FDG-PET/DWIMRI yields excellent results for the detection of post-radio(chemo)therapy HNSCC recurrence.• Prospective one-centre study showed excellent agreement between imaging-based and pathological T-stage.• 97.5% of positive concordant MRI, DWI and FDG-PET results correspond to recurrence.• 87% of discordant MRI, DWI and FDG-PET results correspond to benign lesions.• Multiparametric FDG-PET/DWIMRI facilitates planning of salvage surgery in the irradiated neck.
Highlights
Patients with squamous cell carcinoma of the head and neck (HNSCC) are treated with radio(chemo)therapy, surgery or with a combination thereof [1, 2]
Previous studies have suggested that both magnetic resonance imaging (MRI) with diffusion-weighted imaging (DWI) sequences and FDG positron emission tomography computed tomography (PET/CT) can substantially improve the detection of recurrent head and neck squamous cell carcinoma (HNSCC) [5,6,7,8,9]
There were no adverse effects from performing PET/ DWIMRI or the standard of reference
Summary
Patients with squamous cell carcinoma of the head and neck (HNSCC) are treated with radio(chemo)therapy, surgery or with a combination thereof [1, 2]. Previous studies have suggested that both magnetic resonance imaging (MRI) with diffusion-weighted imaging (DWI) sequences and FDG positron emission tomography computed tomography (PET/CT) can substantially improve the detection of recurrent HNSCC [5,6,7,8,9]. As the combined use of PET/CT and MRI with DWI can add diagnostic certainty in difficult post-treatment situations [1, 9], hybrid PET/MRI systems have raised high hopes in the field of oncological imaging due to the potential to obtain morphological, functional and metabolic information in a single examination [10,11,12,13,14,15,16,17,18,19,20]. The added clinical value of hybrid PET/MRI examinations awaits validation in several oncological applications, including HN tumours [10, 15]
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have